{"type":"PR","pr":{"number":69,"head":"cad02ced923d1e21b9522962902b00c9b87467f2"},"user":"silvia.vernotico","status":"pending_publish","branch":"cms/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.66","description":"Sanofi ha ottenuto dalla Commissione europea l’ok per l’autorizzazione all’immissione in commercio di caplacizumab (ALX-0081), prima terapia specifica per il trattamento della aTTP (porpora trombotica trombocitopenica acquisita).","objects":{"entry":{"path":"site/content/hotthisweek/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66.md","sha":"25cb0d8028144c9b2ca8afdd914ed1b0fcf32d66"},"files":[]},"timeStamp":"2018-11-14T11:02:38.559Z"}